Birdwatch Note
2024-09-23 05:02:02 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
GLP-1 agonists aren't simply just appetite suppressors, they have several positive metabolic benefits: - Increase in basal metabolic rate: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11096862/ - Stimulating brown adipose tissue: https://www.nature.com/articles/s41574-023-00832-5 - Improving insulin sensitivity: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769143/ - Improving liver enzyme function: https://www.nejm.org/doi/full/10.1056/NEJMoa2403347
Written by 7B6C4FC663CBA6BAA3EEC1265014E32496DA4EB435935E84BCDA50F75BC7FBDF
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1837989657822277755
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1838081368237940829
- noteId - 1838081368237940829
- participantId -
- noteAuthorParticipantId - 7B6C4FC663CBA6BAA3EEC1265014E32496DA4EB435935E84BCDA50F75BC7FBDF Participant Details
- createdAtMillis - 1727067722744
- tweetId - 1837989657822277755
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- GLP-1 agonists aren't simply just appetite suppressors, they have several positive metabolic benefits: - Increase in basal metabolic rate: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11096862/ - Stimulating brown adipose tissue: https://www.nature.com/articles/s41574-023-00832-5 - Improving insulin sensitivity: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769143/ - Improving liver enzyme function: https://www.nejm.org/doi/full/10.1056/NEJMoa2403347
Note Ratings
rated at | rated by | |
2024-09-24 13:47:19 -0500 | Rating Details | |
2024-09-24 13:47:05 -0500 | Rating Details | |
2024-09-24 12:12:07 -0500 | Rating Details | |
2024-09-24 09:29:15 -0500 | Rating Details | |
2024-09-24 08:51:39 -0500 | Rating Details | |
2024-09-24 07:57:57 -0500 | Rating Details | |
2024-09-24 07:44:45 -0500 | Rating Details | |
2024-09-24 07:20:11 -0500 | Rating Details | |
2024-09-24 06:48:08 -0500 | Rating Details | |
2024-09-24 06:45:18 -0500 | Rating Details | |
2024-09-24 06:19:48 -0500 | Rating Details | |
2024-09-24 06:07:02 -0500 | Rating Details | |
2024-09-24 05:06:25 -0500 | Rating Details | |
2024-09-24 04:39:01 -0500 | Rating Details | |
2024-09-24 03:43:58 -0500 | Rating Details | |
2024-09-24 02:43:08 -0500 | Rating Details | |
2024-09-24 02:21:43 -0500 | Rating Details | |
2024-09-23 23:27:30 -0500 | Rating Details | |
2024-09-23 22:24:07 -0500 | Rating Details | |
2024-09-23 20:27:47 -0500 | Rating Details | |
2024-09-23 19:48:22 -0500 | Rating Details | |
2024-09-23 19:29:32 -0500 | Rating Details | |
2024-09-23 18:05:29 -0500 | Rating Details | |
2024-09-23 17:46:01 -0500 | Rating Details | |
2024-09-23 17:04:11 -0500 | Rating Details | |
2024-09-23 16:26:14 -0500 | Rating Details | |
2024-09-23 16:25:48 -0500 | Rating Details | |
2024-09-23 16:25:26 -0500 | Rating Details | |
2024-09-23 16:03:41 -0500 | Rating Details | |
2024-09-23 15:58:47 -0500 | Rating Details | |
2024-09-23 15:38:58 -0500 | Rating Details | |
2024-09-23 15:35:18 -0500 | Rating Details | |
2024-09-23 15:21:38 -0500 | Rating Details | |
2024-09-23 15:07:09 -0500 | Rating Details | |
2024-09-23 14:50:56 -0500 | Rating Details | |
2024-09-23 14:33:44 -0500 | Rating Details | |
2024-09-23 14:29:42 -0500 | Rating Details | |
2024-09-23 14:29:32 -0500 | Rating Details | |
2024-09-23 14:24:38 -0500 | Rating Details | |
2024-09-23 13:13:32 -0500 | Rating Details | |
2024-09-23 13:12:06 -0500 | Rating Details | |
2024-09-23 12:26:50 -0500 | Rating Details | |
2024-09-23 12:22:56 -0500 | Rating Details | |
2024-09-23 12:22:37 -0500 | Rating Details | |
2024-09-23 12:13:43 -0500 | Rating Details | |
2024-09-23 12:09:44 -0500 | Rating Details | |
2024-09-23 12:06:44 -0500 | Rating Details | |
2024-09-23 11:56:42 -0500 | Rating Details | |
2024-09-23 11:46:10 -0500 | Rating Details | |
2024-09-23 11:22:18 -0500 | Rating Details | |
2024-09-23 11:13:21 -0500 | Rating Details | |
2024-09-23 10:57:12 -0500 | Rating Details | |
2024-09-23 10:08:52 -0500 | Rating Details | |
2024-09-23 09:50:04 -0500 | Rating Details | |
2024-09-23 09:34:32 -0500 | Rating Details | |
2024-09-23 09:07:19 -0500 | Rating Details | |
2024-09-23 08:48:18 -0500 | Rating Details | |
2024-09-23 08:43:12 -0500 | Rating Details | |
2024-09-23 07:51:42 -0500 | Rating Details | |
2024-09-23 07:48:49 -0500 | Rating Details | |
2024-09-23 07:34:45 -0500 | Rating Details | |
2024-09-23 07:24:24 -0500 | Rating Details | |
2024-09-23 07:22:52 -0500 | Rating Details | |
2024-09-23 06:37:39 -0500 | Rating Details | |
2024-09-23 06:32:11 -0500 | Rating Details | |
2024-09-23 06:28:18 -0500 | Rating Details | |
2024-09-23 06:20:52 -0500 | Rating Details | |
2024-09-23 06:19:01 -0500 | Rating Details | |
2024-09-23 06:16:02 -0500 | Rating Details | |
2024-09-23 06:12:49 -0500 | Rating Details | |
2024-09-23 06:01:36 -0500 | Rating Details | |
2024-09-23 05:57:13 -0500 | Rating Details | |
2024-09-23 05:39:18 -0500 | Rating Details | |
2024-09-23 05:31:38 -0500 | Rating Details | |
2024-09-23 05:29:21 -0500 | Rating Details | |
2024-09-23 05:28:18 -0500 | Rating Details | |
2024-09-23 05:24:32 -0500 | Rating Details | |
2024-09-23 05:13:21 -0500 | Rating Details | |
2024-09-23 05:12:38 -0500 | Rating Details | |
2024-09-23 04:38:45 -0500 | Rating Details | |
2024-09-23 04:25:29 -0500 | Rating Details | |
2024-09-23 04:22:55 -0500 | Rating Details | |
2024-09-23 04:22:17 -0500 | Rating Details | |
2024-09-23 04:06:57 -0500 | Rating Details | |
2024-09-23 03:49:48 -0500 | Rating Details | |
2024-09-23 03:47:44 -0500 | Rating Details | |
2024-09-23 03:44:22 -0500 | Rating Details | |
2024-09-23 03:42:23 -0500 | Rating Details | |
2024-09-23 03:40:45 -0500 | Rating Details | |
2024-09-23 03:35:53 -0500 | Rating Details | |
2024-09-23 03:34:02 -0500 | Rating Details | |
2024-09-23 03:31:35 -0500 | Rating Details | |
2024-09-23 03:28:57 -0500 | Rating Details | |
2024-09-23 03:28:52 -0500 | Rating Details | |
2024-09-23 03:09:51 -0500 | Rating Details | |
2024-09-23 03:04:45 -0500 | Rating Details | |
2024-09-23 02:50:54 -0500 | Rating Details | |
2024-09-23 02:46:40 -0500 | Rating Details | |
2024-09-23 02:42:41 -0500 | Rating Details | |
2024-09-23 02:41:38 -0500 | Rating Details | |
2024-09-23 02:40:43 -0500 | Rating Details | |
2024-09-23 02:32:59 -0500 | Rating Details | |
2024-09-23 02:26:23 -0500 | Rating Details | |
2024-09-23 02:25:59 -0500 | Rating Details | |
2024-09-23 02:19:08 -0500 | Rating Details | |
2024-09-23 01:59:01 -0500 | Rating Details | |
2024-09-23 01:58:23 -0500 | Rating Details | |
2024-09-23 01:56:20 -0500 | Rating Details | |
2024-09-23 01:55:50 -0500 | Rating Details | |
2024-09-23 01:54:03 -0500 | Rating Details | |
2024-09-23 01:53:58 -0500 | Rating Details | |
2024-09-23 01:53:19 -0500 | Rating Details | |
2024-09-23 01:46:18 -0500 | Rating Details | |
2024-09-23 01:42:17 -0500 | Rating Details | |
2024-09-23 01:41:09 -0500 | Rating Details | |
2024-09-23 01:35:26 -0500 | Rating Details | |
2024-09-23 01:22:07 -0500 | Rating Details | |
2024-09-23 01:22:05 -0500 | Rating Details | |
2024-09-23 01:07:04 -0500 | Rating Details | |
2024-09-23 00:39:37 -0500 | Rating Details | |
2024-09-23 00:33:11 -0500 | Rating Details | |
2024-09-23 00:29:45 -0500 | Rating Details | |
2024-09-23 00:27:06 -0500 | Rating Details |